SEVOFLURANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sevoflurane, and when can generic versions of Sevoflurane launch?
Sevoflurane is a drug marketed by Baxter Hlthcare, Halocarbon Prods, Shandong, and Shanghai Hengrui. and is included in four NDAs.
The generic ingredient in SEVOFLURANE is sevoflurane. There are five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sevoflurane profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sevoflurane
A generic version of SEVOFLURANE was approved as sevoflurane by BAXTER HLTHCARE on July 2nd, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SEVOFLURANE?
- What are the global sales for SEVOFLURANE?
- What is Average Wholesale Price for SEVOFLURANE?
Summary for SEVOFLURANE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 92 |
| Clinical Trials: | 856 |
| Patent Applications: | 1,959 |
| Drug Prices: | Drug price information for SEVOFLURANE |
| DailyMed Link: | SEVOFLURANE at DailyMed |
Recent Clinical Trials for SEVOFLURANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Keith M. Vogt, MD, PhD | Phase 1 |
| National Institute of General Medical Sciences (NIGMS) | Phase 1 |
| SanQing Jin | N/A |
Pharmacology for SEVOFLURANE
| Drug Class | General Anesthetic |
| Physiological Effect | General Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for SEVOFLURANE
US Patents and Regulatory Information for SEVOFLURANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | SEVOFLURANE | sevoflurane | LIQUID;INHALATION | 075895-001 | Jul 2, 2002 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Shanghai Hengrui | SEVOFLURANE | sevoflurane | LIQUID;INHALATION | 203793-001 | Nov 3, 2015 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Halocarbon Prods | SEVOFLURANE | sevoflurane | LIQUID;INHALATION | 078650-001 | Nov 19, 2007 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Shandong | SEVOFLURANE | sevoflurane | LIQUID;INHALATION | 214382-001 | Aug 18, 2023 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for SEVOFLURANE
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Chanelle Pharmaceuticals Manufacturing Limited | Sevohale (previously known as Sevocalm) | sevoflurane | EMEA/V/C/004199 For the induction and maintenance of anaesthesia. |
Authorised | yes | no | no | 2016-06-21 | |
| Zoetis Belgium SA | SevoFlo | sevoflurane | EMEA/V/C/000072 For the induction and maintenance of anaesthesia in dogs and cats. |
Authorised | no | no | no | 2002-12-11 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
